ArticleBMC complementary medicine and therapies2026
Buddlejasaponin IV inhibits proliferation and migration via STAT3 suppression in gefitinib-resistant non-small cell lung cancer cells.
Sung Chul Jang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.